Rupture of fetal membranes can initiate parturition at both term and preterm. Collagen is the crucial factor determining the tensile strength of the membranes. Toward the end of gestation, a feed-forward regeneration of cortisol via 11b-hydroxysteroid dehydrogenase 1 exists in fetal membranes. It remains undetermined whether cortisol contributes to collagen reduction in fetal membranes. In this study, we have examined whether cortisol accumulation is a causative factor for collagen reduction in human amnion fibroblasts, the major source of collagens in the membranes. Cortisol had no effect on collagen 1A1 (COL1A1) and 1A2 (COL1A2) messenger RNA (mRNA) abundance but decreased their protein abundance. The latter effect was affected by neither mRNA transcription inhibitor nor protein translation inhibitor. Mechanistic studies revealed that the reduction in COL1A1 but not COL1A2 protein by cortisol was blocked by lysosome inhibitor chloroquine or small interfering RNA (siRNA)-mediated knockdown of autophagy-related protein 7, an essential protein for autophagy, whereas the proteasome inhibitors MG132 and bortezomib were ineffective. Further analysis showed that cortisol dose dependently increased the ratio of LC3II/LC3I, a marker of lysosome activation, an effect blocked by the glucocorticoid receptor (GR) antagonist RU486 and siRNA-mediated knockdown of GR. Consistently, cortisol decreased COL1A1 and COL1A2 protein abundance in amnion tissue explants, and decreased COL1A1 and COL1A2 protein abundance was observed at parturition in the amnion tissue. Conclusively, cortisol regeneration in fetal membranes may contribute to rupture of fetal membranes at parturition by reducing collagen protein abundance. Lysosome-mediated autophagy accounts for the reduction in COL1A1 by cortisol, but the mechanism underlying the reduction in COL1A2 awaits further investigation.
G lucocorticoids, with cortisol being the major biologically active natural form in humans, regulate a number of vital functions in the body (1) . In pregnancy, glucocorticoids are critical in both early and late gestation (2) (3) (4) (5) . In early pregnancy, glucocorticoids balance immune responses to allow the successful implantation of the allograft embryo (3, 4) . In late pregnancy, glucocorticoids not only enhance fetal organ maturation for adaption to extrauterine life, but also initiate parturition in a number of animal species (5, 6) . In addition to the de novo synthesis of glucocorticoids by the adrenal glands, biologically active glucocorticoids can also be regenerated from their inactive counterparts in most glucocorticoid target tissues by 11b-hydroxysteroid dehydrogenase type 1 (11b-HSD1) (7) , which is now regarded as an extra-adrenal source of glucocorticoids (7) (8) (9) . This extra-adrenal regeneration of glucocorticoids is particularly important when full implementation of glucocorticoid's actions is required in specific tissues (7, 8) . In human pregnancy, 11b-HSD1 is abundantly expressed in the fetal membranes and decidual tissue but scarcely expressed in the placental villous tissue (4, 10) . The physiological impact of this unique distribution pattern of 11b-HSD1 within the intrauterine tissues is believed to be associated with events related to labor initiation (11) (12) (13) . Human fetal membranes comprise two concentric tissue layers. The fetal surface of the membranes is the amnion that is composed of a single layer of epithelium supported by a basement membrane resting on a thick collagen layer containing fibroblasts. A thin spongy layer connects the collagen layer to the chorion leave comprised of cytotrophoblasts, and these trophoblasts contact the maternal decidua. In fetal membranes, cortisol derived from 11b-HSD1 not only stimulates the synthesis of prostaglandin E2 (12, 14, 15) and F2a (13) , well-recognized potent uterotonic hormones, but also inhibits the enzyme that degrades prostaglandins (16) . Our recent data suggest that cortisol regenerated by 11b-HSD1 in the fetal membranes also participates in structural remodeling of the amnion, the most tensile layer of the fetal membranes, by inducing apoptosis of amnion epithelial cells (17) and decreasing the abundance of lysyl oxidase (18), a collagen cross-linking enzyme, in amnion fibroblasts, thereby facilitating the process of fetal membrane rupture. Despite the evident role of cortisol in the modification of collagen crosslinking, it remains mostly known whether cortisol regenerated by 11b-HSD1 is engaged in reducing collagen abundance in the fetal membranes.
The tensile strength of the amnion is largely attributed to its collagen content, which mainly consists of type I, III, and V collagens (19, 20) . Previous studies have shown that levels of procollagen I and III subunit messenger RNAs (mRNAs) in the amnion decrease after the first trimester to a nadir until term (21) . In preterm premature rupture of membranes, collagen content is further decreased, suggesting that decreased collagen abundance contributes to the rupture of fetal membranes (22, 23) . Previous efforts at deciphering the mechanisms underlying the reduction in collagen contents in the rupture of membranes were mostly directed to the extracellular degradation by matrix metalloproteases (24) (25) (26) (27) . However, it remains unknown whether autophagy also contributes to the reduction of collagen abundance in the rupture of fetal membranes. Glucocorticoids have been reported to influence lysosome-mediated autophagy in other tissues and organs (28) (29) (30) . In light of the feedforward nature of cortisol regeneration in human fetal membranes (31, 32) , we hypothesize that this mechanism participates in the rupture of membranes through induction of the autophagic degradation of collagens. In this study, we tested this hypothesis in primary human amnion fibroblasts, a major source of collagens, with a focus on a major collagen type, type 1 collagen, which is composed of two a1 chains [collagen 1A1 (COL1A1)] and one a2 chain [collagen 1A2 (COL1A2)] (33).
Materials and Methods

Collection of human fetal membranes
Human fetal membranes were obtained from uncomplicated term (37-to 40-week) pregnancies after elective cesarean section without labor [term nonlabor (TNL)] or after vaginal delivery with spontaneous rupture of the membranes (term labor). Written informed consent was obtained from the patients under a protocol approved by the Ethics Committee of Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University. Pregnancies with complications such as pre-eclampsia, fetal growth restriction, gestational diabetes, and chorioamnionitis, etc., were excluded from this study.
Extraction of protein from the amnion tissue
To compare the amounts of COL1A1 and COL1A2 protein in the amnion tissue with (n = 7) or without (n = 7) labor, the chorion was peeled off and the amnion tissue was cut within 5 cm of the spontaneous (term labor) or artificial (TNL) rupture zones of the membranes, and ground in liquid nitrogen. The ground tissue was homogenized and lysed in ice-cold radioimmune precipitation assay lysis buffer (Active Motif, Carlsbad, CA) containing a protease inhibitor cocktail (Sigma-Aldrich, St. Louis, MO) and phosphatase inhibitor (Active Motif), and centrifuged at 21,000g for 10 minutes at 4°C. Protein in the supernatant was collected for COL1A1 and COL1A2 protein determination with Western blotting, as described later.
Preparation and culture of amnion tissue explants
Human amnion tissue explants were prepared from the TNL amnion (n = 3). Briefly, the amnion was washed with 13 phosphate buffer saline (PBS) containing antibiotics to remove residual blood and cut in circles using a 6-mm skin biopsy punch. The amnion disks were then placed in Falcon cell culture inserts (BD Biosciences, Franklin Lakes, NJ) in a six-well plate in culture medium containing 1:1 mixture of Ham's F12:Dulbecco's modified Eagle medium (DMEM), 10% fetal bovine serum (FBS), and 1% antibiotics (all Life Technologies, Grand Island, NY). The explants were equilibrated at 37°C in 5% CO 2 /95% air for 24 hours. After equilibration, the culture medium was replaced with phenol red/serum-free medium, and then the explants were treated with cortisol (1 mM; SigmaAldrich) for 24 hours and protein was extracted from the amnion tissue explants, as described previously, for the analysis of COL1A1 and COL1A2 protein abundance with Western blotting, as described later.
Isolation and culture of amnion fibroblasts
Human amnion fibroblasts were isolated from the TNL amnion (n = 47). Briefly, after peeling off the chorion, the amnion tissue was digested twice with 0.125% trypsin (Life Technologies), and then washed vigorously with 13 PBS to remove residual epithelial cells. The remaining amnion tissue was digested with 0.1% collagenase (Sigma-Aldrich) to release the fibroblasts from the mesenchymal tissue. After centrifugation of the digestion medium, the pellet was resuspended and layered on Percoll (GE Healthcare BioSciences, Uppsala, Sweden) gradients (5, 20, 40 , and 60%) to further purify the fibroblasts that layered around 40% Percoll. After washing with PBS, the isolated amnion fibroblasts were cultured at 37°C in 5% CO 2 /95% air in DMEM containing 10% FBS plus 1% antibiotics (Life Technologies). The identity of cells was verified by immunocytochemical staining for the mesenchymal cell marker vimentin, and .95% of the cells were positive for vimentin.
Treatment of amnion fibroblasts
Three days after plating, amnion fibroblasts were treated in phenol red/FBS-free culture medium for 24 hours. To examine whether cortisol affected COL1A1 and COL1A2 mRNA and protein abundance, concentration-dependent effects of cortisol (0.01, 0.1, and 1 mM; Sigma-Aldrich) were examined. The abundance of cellular COL1A1 and COL1A2 mRNA and protein was analyzed with quantitative real-time polymerase chain reaction (PCR) and Western blotting, respectively. To further examine whether the effect of cortisol on COL1A1 and COL1A2 abundance occurred at the transcriptional or translational level, the fibroblasts were treated with cortisol (1 mM) in the presence and absence of the transcription inhibitor 5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole (1 mM; Sigma-Aldrich) or the translation inhibitor cycloheximide (CHX; 1 mM; Sigma-Aldrich), and then the cellular COL1A1 and COL1A2 protein abundance was measured with Western blotting.
To analyze whether lysosome-mediated autophagic degradation was involved in the reduction of COL1A1 and COL1A2 protein abundance by cortisol, concentration-dependent effects of cortisol (0.01, 0.1, and 1 mM) on the ratio of LC3BII/I, the markers of lysosome activation (34), were examined. To examine the involvement of lysosome in the degradation of collagen, the fibroblasts were treated with cortisol (1 mM) in the presence and absence of lysosome inhibitor chloroquine (CQ; 50 mM; Sigma-Aldrich) or small interfering RNA (siRNA)-mediated knockdown of autophagy-related protein 7 (ATG7), which encodes an E1-like activating enzyme that is essential for autophagy (35, 36) . To further analyze the involvement of lysosome in the degradation of collagens, the fibroblasts were treated with the lysosome agonist rampamycin (1, 10, and 100 nM; Sigma-Aldrich) or transfected with siRNA against mammalian target of rapamycin (mTOR), which has been reported to inhibit autophagy (37) .
To examine whether a proteasome pathway was involved in the degradation of collagens, the cells were treated with cortisol (1 mM) in the presence and absence of the proteasome inhibitors MG132 (10 nM; Selleck) or bortezomib (50 nM; Selleck). The abundance of cellular COL1A1 and COL1A2 protein was then measured with Western blotting.
To examine the role of glucocorticoid receptor (GR) in the regulation of COL1A1, COL1A2, and LC3BII/I abundance by cortisol, the cells were treated with cortisol (1 mM) in the presence or absence of GR antagonist RU486 (1 mM; SigmaAldrich) or siRNA-mediated knockdown of GR.
Transfection of siRNA in amnion cells with electroporation
To study the role of GR and ATG7 in the mediation of cortisol-induced activation of lysosomes and collagen degradation, amnion fibroblasts were transfected with 50 nM siRNA (GenePharma, Shanghai, China) against GR (5 0 -GCAGCCA-GAUCUGUCCAAATT-3 0 ) or ATG7 (5 0 -GCCUCUCUAUGA-GUUUGAATT-3 0 ). To examine the role of mTOR in the degradation of collagen, the fibroblasts were transfected with 50 nM siRNA (GenePharma) against mTOR (5 0 -CCAA-GAUACCAUGAACCAUTT-3 0 ). Randomly scrambled siRNA (5 0 -UUCUCCGAACGUGUCACGUTT-3 0 ) was used as negative controls. The cells were transfected using an electroporator at 175 V for 5 ms following a previously described protocol (38) . The cells were then incubated in DMEM containing 10% FBS and 1% antibiotics for 3 days before any drug treatments or analysis of collagen protein abundance with Western blotting. The efficiency of knockdown was assessed by measuring the target protein with Western blotting, and shown to be 70%, 65%, and 55% for GR, ATG7, and mTOR, respectively (Supplemental Fig. 1 ).
Quantitative real-time PCR
After treatment, total RNA was extracted from the cells and reverse transcribed to cDNA using a commercial kit (TaKaRa, Dalian, China). The amounts of COL1A1 and COL1A2 mRNA were determined by quantitative real-time PCR using the aforementioned transcribed cDNA and power SYBR Premix Ex Taq (TaKaRa) following a previously described protocol (38) . The absolute mRNA abundance in each sample was calculated from a standard curve set up using serial dilutions of known amounts of specific templates generated by PCR against corresponding cycle threshold values. Housekeeping gene glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was amplified in parallel as an internal control. The primer sequences are as follows: COL1A1, forward, 5
0 -TGCACCTGGTCCCCAAGGCT-3 0 , and reverse, 5
0 -GGCCAGCTGTTCCGGGCAAT-3 0 ; COL1A2, 
Western blotting
After treatment, the cells were lysed in ice-cold radioimmune precipitation assay lysis buffer (Active Motif) containing a protease inhibitor cocktail (Sigma-Aldrich) and phosphatase inhibitor (Active Motif). After determination of protein concentration, the extracted protein was analyzed with Western blotting following a standard protocol, as described previously, using primary antibodies against COL1A1 (1:1000; Novus, Littleton, CO), COL1A2 (1:1000; Proteintech, Wuhan, China), LC3B (1:1000; Novus), ATG-7 (1:1000; Cell Signaling, Danvers, MA), mTOR (1:1000; Cell Signaling), and GR (1:1000; Santa Cruz Biotechnology, Santa Cruz, CA). Internal loading controls were probed with a GAPDH antibody (1:5000; Proteintech). The antibody information used in Western blotting is given in Table 1 .
Transmission electron microscopy
After treatment, human amnion tissue explants were washed with PBS and trimmed into small pieces (1 mm 3 ) with a scalpel and then fast fixed with 2% glutaraldehyde at 4°C for 2 hours. The tissue was washed with PBS at 4°C and postfixed with 1% osmium tetroxide solution for 2 hours at 4°C. The tissue was further processed for dehydration, infiltration, and embedding routinely. Ultrathin sections (70 nm) were cut and stained with lead citrate. Then the sections were observed with a transmission electron microscope (Philips, Eindhoven, Holland; CM-120).
Statistical analysis
All data are reported as mean 6 standard error of the mean. The number in each study represents a separate experiment using amnion cells prepared from a different pregnancy. Statistical analysis was performed with paired or unpaired Student t test or one-way analysis of variance test, followed by the Newman-Keuls multiple comparison test where appropriate. Significance was set at P , 0.05.
Results
Effects of cortisol on COL1A1 and COL1A2 mRNA and protein abundance
Treatment of human amnion fibroblasts with cortisol (0.01, 0.1, and 1 mM; 24 hours) had no effect on COL1A and COL1A2 mRNA abundance [ Fig. 1(a) ], but decreased COL1A and COL1A2 protein abundance in a concentration-dependent manner [ Fig. 1(b) ]. A time course (3, 6, 12, and 24 hours) study confirmed the lack of effect of cortisol (1 mM) on COL1A and COL1A2 mRNA expression [ Fig. 1(c) ] and revealed the significant decrease in COL1A and COL1A2 protein abundance by cortisol at both 12 and 24 hours [ Fig. 1(d)] . Furthermore, the decreases in COL1A and COL1A2 protein abundance induced by cortisol were still observed in the presence of the mRNA transcription inhibitor 5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole (1 mM) [ Fig. 1(e) ] and were further enhanced by the protein translation inhibitor CHX (1 mM) [ Fig. 1(f) ]. These data suggest that cortisol reduces COL1A and COL1A2 protein abundance at the posttranslational level.
Role of GR in cortisol-induced reduction in COL1A and COL1A2 protein abundance Treatment of human amnion fibroblasts with cortisol (1 mM) in the presence of either GR antagonist RU486 (1 mM) [ Fig. 2(a) ] or siRNA-mediated knockdown of GR [ Fig. 2(b) ] blocked cortisol-induced decreases in COL1A and COL1A2 protein abundance, indicating the participation of GR in the downregulation of COL1A and COL1A2 protein abundance by cortisol.
Role of lysosome-mediated autophagy in cortisol-induced reduction in COL1A and COL1A2 protein abundance
Treatment of human amnion fibroblasts with cortisol (0.01, 0.1, and 1 mM) dose dependently increased the ratio of LC3II/LC3I [ Fig. 3(a) ], the marker of lysosome activation. Consistent with the data on COL1A and COL1A2 protein abundance, the upregulation of LC3II/ LC3I ratio by cortisol (1 mM) was blocked by either RU486 (1 mM) [ Fig. 3(b) ] or siRNA-mediated knockdown of GR [ Fig. 3(c) ].
Treatment of amnion fibroblasts with cortisol (1 mM) in the presence and absence of the lysosome inhibitor CQ (50 mM) [ Fig. 3(d) ] or siRNA-mediated knockdown of ATG7 [ Fig. 3(e) ] completely blocked cortisol-induced reduction in COL1A1 but failed to block the effect on COL1A2. Of interest, rampamycin (1, 10, and 100 nM) treatment of amnion fibroblasts decreased both COL1A1 and COL1A2 protein abundance in a concentration-dependent manner [ Fig. 3(f) ]. Likewise, siRNA-mediated knockdown of mTOR decreased both COL1A1 and COL1A2 protein abundance in amnion fibroblasts [ Fig. 3(g) ]. However, the proteasome inhibitors MG132 (10 nM) or bortezomib (50 nM) were ineffective in blocking cortisol-induced reduction in either COL1A1 or COL1A2 protein abundance (Fig. 4) . These data suggest that lysosome-mediated autophagy accounts for the cortisol-induced reduction in COL1A1, (0, 1, 10 , and 100 nM) reduced COL1A1 and COL1A2 protein abundance in a concentration-dependent manner. n = 4. (g) siRNA-mediated knockdown of mTOR decreased both COL1A1 and COL1A2 protein abundance in human amnion fibroblasts. n = 4. Upper panels of (a-g) are representative Western blots. Data are mean 6 standard error of the mean. Statistical analysis was performed with one-way analysis of variance test. *P , 0.05, **P , 0.01, ***P , 0.001 versus control (0); ##P , 0.01 versus cortisol.
whereas the situation with COL1A2 appears more complicated. However, the proteasome pathway does not appear to be associated with the downregulation of either COL1A1 or COL1A2 protein by cortisol in human amnion fibroblasts.
Changes in COL1A1 and COL1A2 protein abundance in human amnion tissue explants following cortisol treatment and in amnion tissue at parturition Treatment of human amnion tissue explants with cortisol (1 mM) decreased COL1A1 and COL1A2 protein abundance in cultured amnion tissue explants [ Fig. 5(a) ]. Electron microscopic observation revealed that collagen fibrils were abundant, mostly of uniform diameters, and organized in a regular pattern in the amnion tissue of the control group [ Fig. 5(b) ]. After treatment with cortisol (1 mM) for 24 hours, the abundance of collagen appeared reduced, and collagen fibrils were disorganized and dispersed [ Fig. 5(b) ]. Measurement of COL1A1 and COL1A2 protein abundance in the amnion tissue obtained after spontaneous labor showed that there were significant decreases in both when compared with the amnion tissue obtained after cesarean section without labor [ Fig. 5(c) ].
Discussion
In this study, we present evidence for the posttranslational downregulation of COL1A1 and COL1A2 protein abundance by cortisol in human amnion fibroblasts. Alfaidy et al. (39) have shown that 11b-HSD1 expression in human fetal membranes increases in late gestation, and our group has demonstrated that cortisol, a product of 11b-HSD1 reductase activity, induces rather than inhibits 11b-HSD1 expression in human amnion fibroblasts (31, 32) . This feedforward induction of 11b-HSD1 expression by cortisol may explain the concomitant increase in 11b-HSD1 expression and cortisol abundance seen in fetal membranes with advancing gestational age (9, 17, 38, 39) . Given this feedforward regeneration of cortisol by 11b-HSD1 in the fetal membranes (31, 32), we believe that the reduction in COL1A1 and COL1A2 protein abundance in human amnion tissue with labor is associated, at least in part, with the accumulation of cortisol in the tissue. This notion is supported by the downregulation of COL1A1 and COL1A2 protein abundance by cortisol in amnion fibroblasts as well as in amnion tissue explants. Our data are in line with the study by Guller et al. (40) showing that dexamethasone, a synthetic glucocorticoid, can reduce collagen III synthesis in human amnion epithelial cells.
Because collagen content is the major source of tensile strength of the amnion (20) , the reduction in collagen protein abundance induced by cortisol might be associated with the rupture of fetal membranes, which can initiate labor both at term (41) and preterm (20, 22, 23) . Recently, our group has demonstrated that cortisol also reduces the expression of lysyl oxidase (18) , an enzyme that cross-links collagens to intensify collagen strength, in human amnion fibroblasts. Therefore, we believe that cortisol regenerated by 11b-HSD1 in the amnion not only reduces the abundance of collagens but also alters their structure, and these effects may work in concert to decrease membrane tensile strength, which ultimately leads to membrane rupture. Our findings in the amnion are consistent with an observation in the skin that 11b-HSD1 blockade prevents age-induced degradation of collagens and defects in skin structure and function (42) .
It should be kept in mind that multiple factors may contribute to the reduction of collagens toward the end of gestation, including a decline in the density of mesenchymal cells (21) , which are the major source of collagens in the compact layer of the amnion (20, 43) . In addition, increased accumulation of proinflammatory cytokines has been observed in the fetal membranes at both infection-induced labor and normal labor (44) (45) (46) , and proinflammatory cytokines have been demonstrated to be potent activators of matrix metalloproteinases (47, 48) , which degrade extracellular collagens.
In this study, we provided evidence that lysosomemediated autophagic degradation of COL1A1 may be responsible for the effect of cortisol because complete blockade of the reduction in COL1A1 protein abundance induced by cortisol was observed by inhibition of lysosome function. We found that not only the degradation of COL1A1 but also the activation of lysosome function by cortisol was mediated by GR in amnion fibroblasts. However, at the current stage, we are unclear how cortisol increases the ratio of LC3II/ LC3I through GR to activate the lysosome pathway.
Although we found that both rampamycin and siRNA-mediated knockdown of mTOR were capable of reducing both COL1A1 and COL1A2 protein abundance, it appears unlikely that lysosome-mediated autophagy is responsible for the reduction in COL1A2 protein abundance induced by cortisol because inhibition of lysosome function with either CQ or siRNA-mediated knockdown of ATG-7 failed to block the reduction in COL1A2 protein abundance induced by cortisol. It has been reported that the blockade of mTOR signaling pathways by rampamycin (49) or siRNA-mediated knockdown of mTOR is associated not only with lysosome-mediated autophagy (37) , but also a myriad of pathways that affect the stability of the protein (50, 51) . Therefore, we speculate that the reduction in COL1A2 protein abundance by cortisol in amnion fibroblasts may be mediated by alternative posttranslational proteolytic pathways rather than the lysosome or proteasome pathway.
In conclusion, this study has demonstrated that cortisol accumulation accounts, at least in part, for the reduction in COL1A1 and COL1A2 protein abundance in the amnion at parturition. The downregulation of collagens by cortisol may be implicated in the rupture of fetal membranes at both term and preterm labor. In addition, we provided evidence for lysosome-mediated autophagy in the degradation of COL1A1 by cortisol in amnion fibroblasts. (c) Protein abundance of COL1A1 and COL1A2 in human amnion tissue was decreased after spontaneous labor at term (labor) (n = 7) in comparison with that of elective cesarean section without labor at term (nonlabor) (n = 7). Data are mean 6 standard error of the mean. Statistical analysis was performed with paired (a) or unpaired (c) Student t test. *P , 0.05 versus control or nonlabor.
